No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a Han Chinese population by Xu, Yuping et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Debate
No association of the insulin gene VNTR polymorphism with 
polycystic ovary syndrome in a Han Chinese population
Yuping Xu1,2, Zhaolian Wei1, Zhiguo Zhang1, Qiong Xing1, Pin Hu1, 
Xiaohui Zhang1, Guihua Gao1, Yong Wang2, Qian Gao2, Long Yi*2 and 
Yunxia Cao*1
Address: 1Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, 230022, China and 2Department 
of Pathology, Nanjing University Medical School, Nanjing, 210093, China
Email: Yuping Xu - allin0701@gmail.com; Zhaolian Wei - weizhaolian_1@126.com; Zhiguo Zhang - zzg_100@163.com; 
Qiong Xing - joan2004207@gmail.com; Pin Hu - sayhow@sohu.com; Xiaohui Zhang - cathyzxh4322@163.com; 
Guihua Gao - gaoguihua2006@163.com; Yong Wang - wy_518@yahoo.com.cn; Qian Gao - qian_gao@nju.edu.cn; 
Long Yi* - yilong@nju.edu.cn; Yunxia Cao* - caoyunxia6@126.com
* Corresponding authors    
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated
with an increased risk of type II diabetes mellitus. The results of previous research about the
association of the VNTR polymorphism in 5-prime flanking region of the insulin (INS) gene with
PCOS have been inconsistent. The present study was to investigate the association of the INS-
VNTR polymorphism with PCOS in a Han Chinese population.
Methods:  The -23/HphI polymorphism as a surrogate marker of the INS-VNTR length
polymorphism was genotyped by polymerase chain reaction and restriction fragment length
polymorphism (PCR-RFLP) in 216 PCOS patients and 192 non-PCOS women as a control group.
Allelic and genotypic frequencies were compared between patients and controls, and these results
were analyzed in respect to clinical test data.
Results: No significant differences were observed between the cases and controls groups either
in allele (P = 0.996) or genotype (P = 0.802) frequencies of INS-VNTR polymorphism; Regarding
anthropometric data and hormone levels, there were no significant differences between INS-VNTR
genotypes in the PCOS group, as well as in the non-PCOS group.
Conclusion: The present study demonstrated for the first time that the INS-VNTR polymorphism
is not a key risk factor for sporadic PCOS in the Han Chinese women. Further studies are needed
to give a global view of this polymorphism in pathogenesis of PCOS in a large-scale sample, family-
based association design or well-defined subgroups of PCOS.
Background
Polycystic ovary syndrome (PCOS) is a common endo-
crine disorder affecting up to 4% of women of reproduc-
tive age. The disorder is characterized by
hyperandrogenism, menstrual irregularities and often
central obesity. Moreover, it is associated with an
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increased risk of type II diabetes mellitus [1]. Colilla et al.
demonstrated that there is a heritable component in beta-
cell dysfunction in families of women with PCOS, and
that heritability of beta-cell dysfunction is likely to be a
significant factor in the predisposition to diabetes in
PCOS [2].
The insulin (INS) gene locates at chromosome 11p15.5
and is one of established susceptibility locus to type II dia-
betes in Caucasians [3]. In the 5-prime flanking region of
the INS gene, a variable number of tandem repeat (VNTR)
regulates transcription of the gene; the shortest (class I)
alleles were found to increase, whereas the longest (class
III) alleles were observed to decrease in the patients in
comparison to the controls [4,5]. It was reported that
most class III alleles are associated with higher levels of
INS transcription than class I alleles in the thymus [6,7].
The higher INS expression may more efficiently induce
tolerance to insulin. An A/T single nucleotide polymor-
phism (SNP) located at -23 bp is highly linked with the
INS-VNTR length polymorphism. The SNP can be
digested by the restriction endonuclease HphI and exhib-
its restriction fragment length polymorphism which is
called "-23/Hph I polymorphism" as a surrogate marker
of the INS-VNTR length polymorphism [8].
The association between the polymorphism and PCOS
has been observed in Caucasians but the results were
inconsistent. Waterworth et al were the first to provide evi-
dence on a linkage of PCOS with the INS gene VNTR locus
and an association between VNTR class III alleles and the
subset of anovulatory PCOS subjects [9]. A study of 74 UK
women with PCOS reported an association between the
class III allele and increasing severity of clinical phenotype
[10]. On the contrary, three independent research groups
failed to replicate the association [11-13]. On account of
these controversial reports, the association has to be con-
firmed by independent studies in different ethnic groups.
The purpose of the present study is to examine the genetic
association of the -23/Hph I polymorphism in the INS
gene with PCOS in a Han Chinese population.
Methods
Subject
The subjects were recruited from patients who visited the
Department of Obstetrics and Gynecology of the First
Affiliated Hospital of Anhui Medical University during
December 2005 and December 2006, including 216
PCOS patients and 192 non-PCOS women as a control
group. The inclusion criteria of the PCOS group was based
on the Rotterdam diagnostic criteria [14], while the eligi-
bility criteria of non-PCOS women included: menstrual
period < 35 d (most women had been pregnant or given
birth to at least one child), precluding obesity, hirsutism,
acne, excess sebum production and insulin resistance. All
subjects were ethnic Han Chinese living in Anhui prov-
ince and had not received hormonal therapy for at least 3
months before hormonal assays. After informed consent
was obtained, blood was drawn from the subjects for hor-
monal assays and DNA analysis under the supervision of
the Ethical Committee of the First Affiliated Hospital,
Anhui Medical University. The peripheral blood was
obtained between 8 AM and 9 AM after a 12-hour over-
night fast during the 3rd to the 5th day of the menstrual
cycle.
Hormonal assays
The level of serum follicle-stimulating hormone (FSH),
luteinizing hormone (LH), total testosterone (T), estrogen
(E2) and prolactin (PRL) were determined using Com-
mercially available human chemiluminescence enzyme
immunoassay kits (ROCHE DIAGNOSTICS GMBH, Man-
nheim, Germany). The intra- and inter-assay coefficients
of variation of all the assays were less than 10%.
Genotyping
Genomic DNA was prepared from peripheral blood leu-
kocytes by using the Chelex-100 method [15]. INS-23/
Hph I polymorphism was determined using the polymer-
ase chain reaction and restriction fragment length poly-
morphism (PCR-RFLP) method [12]. The PCR reaction
mixture contained 50 ng genomic DNA, 0.5 μM of each
primer (forward: 5'-AGC AGG TCT GTT CCA AGG-3' and
reverse: 5'-CTT GGG TGT GTA GAA GAA GC-3'), 10 mM
Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 0.1% Tri-
ton X-100, 0.2 mM of each dNTP, and 0.75 unit Tag DNA
polymerase (Promega, USA) in a final volume of 25 ml.
Representative allele patterns of genotyping for INS-23Hph I  polymorphism on 2.5% agarose gel Figure 1
Representative allele patterns of genotyping for INS-
23Hph I polymorphism on 2.5% agarose gel. M: DNA 
marker; L1 and L4: bands of 191 plus 129 bp indicating geno-
type AA; L2, L3 and L5: bands of 231 and 191 plus 129 bp 
indicating genotype AT;Reproductive Biology and Endocrinology 2009, 7:141 http://www.rbej.com/content/7/1/141
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The reaction mixture was subjected to denaturation at
96°C for 2 min, followed by 30 cycles at 94°C for 1 min,
62°C for 1 min, 72°C for 1 min, then by a final extension
at 72°C for 10 min. The PCR products were 360 bp and
were digested with the Hph I restriction enzyme at 37°C
for about 18 h. After digested products were electro-
phoresed on a 2.5% agarose gel and visualized by ethid-
ium bromide staining, the T and A alleles could be
distinguished as bands of 231 plus 129 bp and 191 plus
129 bp, respectively. Representative allele patterns of gen-
otyping are illustrated in Figure 1.
Statistical analysis
The standard X2 tests were used to compare allele or gen-
otype frequencies in PCOS and non-PCOS groups and
among different ethnic groups, and verify the Hardy-
Weinberg equilibrium of genotype frequencies. The
results of serum hormone levels were reported as MEANS
± SD. Differences in anthropometric data and serum hor-
mone levels between PCOS and non-PCOS groups were
assessed by using Student's t-test. P < 0.05 was considered
significant for all tests. Statistical analyses were performed
using the SPSS statistical software (SPSS Inc., Chicago, IL).
Results
Table 1 shows comparison of anthropometric data and
hormone levels between PCOS and non-PCOS groups
(some subjects whose hormone measurement is different
from that presented in the Materials and Methods have
been excluded). There is no significant difference in
menarche age, FSH and PRL between the two groups. The
BMI, serum LH, LH/FSH and serum T of the PCOS group
are significantly higher than those of the non-PCOS
group, which is consistent with the clinical characteristics
of PCOS [14]. However, the level of E2 was also signifi-
cantly higher in the PCOS group compared to the control.
The unexpected result cannot be explained easily and fur-
ther studies may be needed to address the issue.
The allele and genotype distributions for both PCOS and
non-PCOS groups were consistent with the Hardy-Wein-
berg equilibrium, and are shown in Table 2. Frequencies
of the allele T and genotype AT plus TT of non-PCOS
(7.3% and 14%, respectively) were significantly different
to those previously published in the Japan population
(3.3% and 6.5%, respectively, P < 0.05) [16] and UK Cau-
casians (27.9 and 47.4, respectively, P < 0.05) [13]. In the
association study, no significant difference between cases
and controls was observed either in allele (P = 0.996) or
in genotype (P = 0.802) frequencies, indicating that there
was no association between INS-23/Hph I polymorphism
and the incidence of sporadic PCOS cases in the Han Chi-
nese population.
As indicated in Table 3, there was no significant difference
regarding anthropometric data and hormone levels
between INS-23/Hph I genotypes in the PCOS group and
those in the non-PCOS group.
Discussion
The association of the VNTR polymorphism in 5-prime
flanking region of the INS gene susceptible to type II dia-
betes with PCOS have been studied over the years in dif-
ferent populations, and the results observed have been
inconsistent and controversial. No such data is available
in the Han Chinese population. In the present study we
have analyzed for the first time the association between
the polymorphism of PCOS and anthropometric data and
hormone levels.
Table 1: Anthropometric data and hormone levels of PCOS and non-PCOS groups
Group N Age
(years)
Menarche 
age
(years)
BMI (kg/m2) FSH 
(IU/ml)
LH 
(IU/ml)
LH/FSH T 
(nmol/L)
E2 
(pmol/L)
PRL 
(ng/ml)
PCOS 190 26.81 ± 
4.25*
14.49 ± 
1.62
23.08 ± 3.65* 6.38 ± 4.37 14.06 ± 
8.38*
2.40 ± 
1.27*
2.30 ± 
1.09*
228.32 ± 
166.28*
15.35 ± 
8.53
Non-PCOS 157 31.53 ± 
4.31
14.66 ± 
2.41
21.27 ± 2.24 6.97 ± 2.08 4.46 ± 2.10 0.66 ± 0.32 1.65 ± 3.92 179.75 ± 
143.00
18.42 ± 
20.71
Note: *P < 0.05 vs non-PCOS. Some subjects whose hormone measurement is different from that presented in the Materials and Methods have 
been excluded.
Table 2: Allelic and genotypic frequencies of INS-23/Hph I polymorphism
Allele n (%) Genotype n (%)
Subjects A T P A//A A//T T//T P
PCOS 407 (94.2) 25 (5.8) 0.996 193 (89.4) 21 (9.7) 2 (0.9) 0.802
Non PCOS 356 (92.7) 28 (7.3) 165 (85.9) 26 (13.5) 1 (0.5)Reproductive Biology and Endocrinology 2009, 7:141 http://www.rbej.com/content/7/1/141
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Some of PCOS phenotypes have been linked to the INS-
VNTR. Waterworth et al. were the first to provide the evi-
dence on an association between VNTR class III alleles
and the subset of anovulatory and hyperinsulinaemic
PCOS subjects in a recessive genetic model [9]. Ferk et al.
also found that Class III INS-VNTR alleles were signifi-
cantly more frequent in the Slovene PCOS patients and
the interaction of obesity and the III/III INS VNTR geno-
type might be a risk factor in the development of PCOS
[17].
In this study, we demonstrate that there is no association
between INS-23/Hph I polymorphism and PCOS in the
Han Chinese population. Moreover, further analysis
showed that there was no significant difference regarding
anthropometric data and hormone levels between INS-
VNTR genotypes in the PCOS group, as well as in the non-
PCOS group. The results were consistent to those previ-
ously reported [11-13]. After investigating 96 hyperandro-
genic patients and 38 healthy control women, Calvo et al.
concluded that there is no association between INS-VNTR
and PCOS or hyperandrogenism, at least in Spanish
women [12]. Subsequently, in a large-scale research on
255 nuclear families and about 3000 subjects from two
populations (Britisher/Irisher and Finlander), Powell et
al. revealed that INS-VNTR was not a key factor in the
pathogenesis and progress of PCOS [13]. It should be
noted that studies to date failed to confirm a significant
association with the PCOS in general.
There are several possible explanations for these inconsist-
ent results of association between the INS-VNTR and
PCOS. Previous studies including this one showed the
allele and genotype of the VNTR polymorphism in INS
gene were different among ethical populations. Osawa et
al. found the A allele frequency of -23/HphI polymor-
phism was 97.4% in Japanese subjects, whereas in Euro-
peans it was about 30% [18]. The results in this study
showed the A allele frequency was about 93.5% (Table 2).
Because of the predominance of class I over class III alleles
in Asian population, further study with large-scale sample
design is needed for us to ascertain the association
between the INS-VNTR and PCOS. Case-control study is a
common and powerful design to detect genetic contribu-
tions to complex diseases like PCOS. Unfortunately, a
small portion of differences in allele frequencies between
cases and controls could be attributable to diversity in
background population, which is called population strat-
ification. Family-based association designs like transmis-
sion disequilibrium test measure the over-transmission of
an allele from heterozygous parents to affected offsprings.
The designs do not use control groups and can overcome
this disadvantage effectively [19], and would be an alter-
native way to assess the risk of PCOS.
In this study, we did not assess Insulin levels and Insulin
resistance of the subjects. We will address the issue of
whether subgroups of PCOS are associated with INS-
VNTR polymorphism by investigating clinical and bio-
chemical features related to glucose metabolism among
PCOS women.
Conclusion
The present study demonstrated for the first time that the
INS-VNTR polymorphism is not a key risk factor in spo-
radic PCOS in the Han Chinese women. Further studies
are needed to give a global view of this polymorphism in
pathogenesis of PCOS in a large-scale sample, family-
based association design or well-defined subgroups of
PCOS.
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